Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Benitec Biopharm Ads (BNTC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,627
  • Shares Outstanding, K 10,260
  • Annual Sales, $ 8,360 K
  • Annual Income, $ -4,290 K
  • 36-Month Beta 3.39
  • Price/Sales 3.99
  • Price/Cash Flow N/A
  • Price/Book 2.72

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.06 +3.92%
on 03/27/18
3.59 -11.42%
on 04/12/18
-0.12 (-3.64%)
since 03/23/18
3-Month
2.76 +15.22%
on 02/28/18
3.74 -14.97%
on 01/24/18
-0.20 (-5.92%)
since 01/23/18
52-Week
1.85 +71.89%
on 07/07/17
4.20 -24.29%
on 01/16/18
+0.54 (+20.45%)
since 04/21/17

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B,...

See More

Key Turning Points

2nd Resistance Point 3.21
1st Resistance Point 3.19
Last Price 3.18
1st Support Level 3.17
2nd Support Level 3.17

See More

52-Week High 4.20
Fibonacci 61.8% 3.30
Last Price 3.18
Fibonacci 50% 3.02
Fibonacci 38.2% 2.75
52-Week Low 1.85

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar